Activate Learning Launches Innovative Virtual Investigations for Middle School Science at NSTA Conference in Philadelphia
Teachers are praising the Activate Learning Virtual Investigations™ as a practical and effective tool for supporting absent students and reviewing lab activities without needing to reset equipment or materials.
Share
This cutting-edge digital tool is designed to bring science to life through immersive, standards-aligned virtual lab experiences. The Activate Learning Virtual Investigations™ are designed to complement hands-on learning by providing a seamless, curriculum-aligned alternative that enhances student engagement and access to phenomena.
Developed to support Activate Learning's middle school science curriculum, the Activate Learning Virtual Investigations™ directly align with OpenSciEd Middle School content and are fully integrated with the Activate Learning Digital Platform, making it easy for educators to deliver engaging, interactive learning experiences with minimal prep.
'Virtual Investigations provide students with an authentic scientific inquiry experience that's both engaging and accessible,' said Activate Learning CEO Eric Johnson. 'By integrating interactive digital tools directly into our curriculum, we're helping educators bridge the gap between hands-on learning and the digital world their students already inhabit.'
Educators and attendees at the recent NSTA Conference in Philadelphia were among the first to experience the new virtual investigations firsthand during live demonstrations at the Activate Learning booth.
Educator feedback at the NSTA Conference was overwhelmingly positive, with teachers praising the Activate Learning Virtual Investigations™ as a practical and effective tool for supporting absent students and reviewing lab activities without needing to reset equipment or materials. Many educators noted how these virtual labs can save time while still reinforcing essential scientific practices and concepts.
'Teachers are always looking for flexible, high-quality solutions that meet the needs of real classrooms,' said David Robertshaw, Chief Product Officer at Activate Learning. 'Virtual Investigations deliver just that—engaging, standards-aligned experiences that work whether students are present, reviewing, or catching up. The enthusiasm we saw at NSTA confirmed we're meeting a real need.'
Activate Learning is hosting a free informational webinar session on Wednesday, April 30th at 1pm Pacific / 4pm Eastern Time for educators to experience the new Virtual Investigations. As a bonus, all webinar attendees will receive exclusive demo access to sample Virtual Investigations!
At Activate Learning, we believe there is a better way to engage students in STEM. Our K-12, investigation-centered science curriculum engages students with authentic learning and phenomena that are relevant and meaningful. We inspire teachers with research-based curricula that support three-dimensional learning and prepare students for the careers of tomorrow.
To learn more about how we can help bring transformational learning to your classroom, visit https://activatelearning.com.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Wire
an hour ago
- Business Wire
Pulse Biosciences Reports Business Updates and Second Quarter 2025 Financial Results
HAYWARD, Calif.--(BUSINESS WIRE)--Pulse Biosciences, Inc. (Nasdaq: PLSE), a company leveraging its novel and proprietary Nanosecond Pulsed Field Ablation™ (nanosecond PFA or nsPFA™) technology, today announced business updates and financial results for the second quarter ended June 30, 2025. Recent Business Highlights Soft Tissue Ablation Expanded the pilot program for the nsPFA Percutaneous Electrode for soft tissue ablation. Treated over 140 Benign Thyroid Nodule patients to date across multiple pilot program centers. Identified five sites to participate in a post-market study of the treatment of benign thyroid disease, with plans to commence enrollment in Q3 upon receipt of IRB approvals. Surgical AF Ablation Submitted FDA IDE application, including the pivotal study protocol, to support a premarket approval (PMA) application for the treatment of atrial fibrillation (AF) and remain on track to commence the IDE pivotal study in the next few months. Treated 40 patients to date and generated positive clinical outcomes, as indicated by follow up remapping procedures, as part of the nsPFA Cardiac Surgery System multi-center, first-in-human AF feasibility study in Europe. Endocardial Catheter AF Ablation Submitted FDA IDE application, including the pivotal study protocol, and remain on track to commence the IDE pivotal study in the next few months. Observed improved procedure times since last presented at the Heart Rhythm Society 2025 Meeting in April. Treated over 140 total patients with the nsPFA 360° catheter to date as part of the multi-center, first-in-human AF study in Europe. 'We are advancing the top priorities established at the beginning of 2025 for each of our three market development programs,' said Paul LaViolette, CEO and Co-Chairman of Pulse Biosciences. 'I am delighted to announce that we have expanded the pilot program for the Percutaneous Electrode for soft tissue ablation, submitted our IDE for both the cardiac surgical clamp and nsPFA 360° catheter, all while continuing to treat more patients and generate positive clinical outcomes with our cardiac devices in their respective feasibility studies in Europe. These achievements further reinforce the transformational potential of nsPFA energy for treating benign thyroid disease, AF and additional diseases in the future.' Second Quarter 2025 Financial Results Total GAAP costs and expenses, representing research and development and general and administrative expenses, for the three months ended June 30, 2025, were $20.3 million, an increase of $8.5 million compared to $11.7 million in the prior year period. The increase was primarily driven by administrative expenses related to the expanding organization to support advancement of the nsPFA device clinical trials and commercialization, and non-cash stock-based compensation and other compensation. Non-GAAP costs and expenses for the three months ended June 30, 2025, were $14.8 million, an increase of $5.4 million compared to $9.4 million in the prior year period. GAAP net loss for the three months ended June 30, 2025 was ($19.2) million compared to ($11.4) million for the three months ended June 30, 2024. Non-GAAP net loss for the three months ended June 30, 2025 was ($13.7) million compared to ($9.0) million for the three months ended June 30, 2024. Cash and cash equivalents totaled $106.3 million as of June 30, 2025, compared to $26.2 million as of June 30, 2024 and $119.3 million as of March 31, 2025. Cash used in operating activities in the second quarter of 2025 totaled $12.8 million, compared to $8.4 million used in the same period in the prior year, and $13.5 million used in the first quarter of 2025. Reconciliations of GAAP to Non-GAAP cost and expenses and net loss have been provided in the tables following the financial statements in this press release. An explanation of these measures is also included below under the heading 'Non-GAAP Financial Measures.' Webcast and Conference Call Information Pulse Biosciences' management will host a conference call today, August 12, 2025, beginning at 1:30pm PT. Investors interested in listening to the conference call may do so by dialing 1-800-715-9871 or 1-646-307-1963 and providing passcode 2036874. A live and recorded webcast of the event will be available at About Pulse Biosciences ® Pulse Biosciences is a novel bioelectric medicine company committed to health innovation that has the intention as well as the potential to improve the quality of life for patients. The Company's proprietary CellFX® nsPFA™ technology delivers nanosecond pulses of electrical energy to non-thermally clear cells while sparing adjacent noncellular tissue. The Company is actively pursuing the development of its CellFX nsPFA technology for use in the treatment of atrial fibrillation and in a select few other markets where it could have a profound positive impact on healthcare for both patients and providers, such as surgical soft tissue ablation. Pulse Biosciences, CellFX, Nano-Pulse Stimulation, NPS, nsPFA, CellFX nsPFA, nanosecond PFA and the stylized logos are among the trademarks and/or registered trademarks of Pulse Biosciences, Inc. in the United States and other countries. Non-GAAP Financial Measures In this press release, in order to supplement the Company's condensed consolidated financial statements presented in accordance with Generally Accepted Accounting Principles, or GAAP, management has disclosed certain non-GAAP financial measures for the statement of operations. The Company believes that an evaluation of its ongoing operations (and comparisons of its current operations with historical and future operations) would be difficult if the disclosure of its financial results were limited to financial measures prepared in accordance with GAAP. As a result, the Company is disclosing certain non-GAAP results in order to supplement investors' and other readers' understanding and assessment of the Company's financial performance. Company management uses these measurements as aids in monitoring the Company's ongoing financial performance from quarter to quarter, and year to year, on a regular basis and for financial and operational decision-making. Non-GAAP adjustments include stock-based compensation, depreciation and amortization, restructuring, severance, and a legal settlement. From time to time in the future, there may be other items that the Company may exclude if the Company believes that doing so is consistent with the goal of providing useful information to management and investors. The Company has provided a reconciliation of each non-GAAP financial measure used in this earnings release to the most directly comparable GAAP financial measure. Investors are cautioned that there are a number of limitations associated with the use of non-GAAP financial measures as analytical tools. Investors are encouraged to review these reconciliations, and not to rely on any single financial measure to evaluate the Company's business. Non-GAAP financial measures used by the Company may be calculated differently from, and therefore may not be comparable to, similarly titled measures used by other companies, which could reduce the usefulness of the Company's non-GAAP financial measures as tools for comparison. Investors and other readers are encouraged to review the related GAAP financial measures and the reconciliation of non-GAAP measures to their most directly comparable GAAP measures set forth below and should consider non-GAAP measures only as a supplement to, not as a substitute for or as a superior measure to, measures of financial performance prepared in accordance with GAAP. Non-GAAP financial measures in this earnings release exclude non-cash expenses for stock-based compensation, depreciation and amortization, restructuring costs, severance expense and legal settlement expenses. Forward-Looking Statements All statements in this press release that are not historical are forward-looking statements, including, among other things, statements relating to the effectiveness of the Company's nsPFA technology and CellFX System to non-thermally clear cells while sparing adjacent non-cellular tissue, statements concerning the Company's future commercialization and product development efforts and whether those efforts will be successful, statements concerning early clinical successes and whether they are predictive of the safety and effectiveness of any medical device, such as the nsPFA 360° Cardiac Catheter System, the nsPFA Cardiac Surgical System, and the nsPFA Percutaneous Electrode System, and statements concerning the Company's future clinical and regulatory initiatives anywhere in the world, and other future events. These statements are not historical facts but rather are based on Pulse Biosciences' current expectations, estimates, and projections regarding Pulse Biosciences' business, operations and other similar or related factors. Words such as 'may,' 'will,' 'could,' 'would,' 'should,' 'anticipate,' 'predict,' 'potential,' 'continue,' 'expects,' 'intends,' 'plans,' 'projects,' 'believes,' 'estimates,' and other similar or related expressions are used to identify these forward-looking statements, although not all forward-looking statements contain these words. You should not place undue reliance on forward-looking statements because they involve known and unknown risks, uncertainties, and assumptions that are difficult or impossible to predict and, in some cases, beyond Pulse Biosciences' control. Actual results may differ materially from those in the forward-looking statements as a result of a number of factors, including those described in Pulse Biosciences' filings with the Securities and Exchange Commission. Pulse Biosciences undertakes no obligation to revise or update information in this release to reflect events or circumstances in the future, even if new information becomes available. PULSE BIOSCIENCES, INC. Condensed Consolidated Statements of Operations and Comprehensive Loss (In thousands, except per share amounts) (Unaudited) Three-Month Periods Ended Six-Month Periods Ended June 30, June 30, 2025 2024 2025 2024 Revenues: Product revenues $ — $ — $ — $ — Total revenues — — — — Cost and expenses: Research and development 12,088 7,230 22,401 13,971 General and administrative 8,187 4,496 15,918 8,370 Total cost and expenses 20,275 11,726 38,319 22,341 Loss from operations (20,275 ) (11,726 ) (38,319 ) (22,341 ) Other income: Interest income, net 1,107 343 2,356 821 Total other income 1,107 343 2,356 821 Net loss (19,168 ) (11,383 ) (35,963 ) (21,520 ) Comprehensive loss $ (19,168 ) $ (11,383 ) $ (35,963 ) $ (21,520 ) Net loss per share: Basic and diluted net loss per share $ (0.28 ) $ (0.20 ) $ (0.54 ) $ (0.38 ) Weighted average shares used to compute net loss per common share — basic and diluted 67,276 57,180 67,201 57,152 Expand Reconciliation of GAAP to Non-GAAP Financial Measures The following table presents the reconciliation of non-GAAP financial measures to the most directly comparable GAAP financial measures: (In thousands) (Unaudited) Three-Month Periods Ended Six-Month Periods Ended June 30, June 30, 2025 2024 2025 2024 Reconciliation of GAAP to non-GAAP Research and development: GAAP Research and development $ 12,088 $ 7,230 $ 22,401 $ 13,971 Less: Stock-based compensation expense (2,335 ) (1,001 ) (5,097 ) (1,950 ) Less: Depreciation and amortization (44 ) (52 ) (90 ) (105 ) Non-GAAP Research and development $ 9,709 $ 6,177 $ 17,214 $ 11,916 Reconciliation of GAAP to non-GAAP General and administrative: GAAP General and administrative $ 8,187 $ 4,496 $ 15,918 $ 8,370 Less: Stock-based compensation expense (2,854 ) (1,051 ) (5,773 ) (1,861 ) Less: Depreciation and amortization (229 ) (246 ) (466 ) (492 ) Add: Legal settlement — — 590 — Non-GAAP General and administrative $ 5,104 $ 3,199 $ 10,269 $ 6,017 Reconciliation of GAAP to non-GAAP Cost and expenses: GAAP Cost and expenses $ 20,275 $ 11,726 $ 38,319 $ 22,341 Less: Stock-based compensation expense (5,189 ) (2,052 ) (10,870 ) (3,811 ) Less: Depreciation and amortization (273 ) (298 ) (556 ) (597 ) Add: Legal settlement — — 590 — Non-GAAP Cost and expenses $ 14,813 $ 9,376 $ 27,483 $ 17,933 Reconciliation of GAAP to non-GAAP Net loss: GAAP Net loss $ (19,168 ) $ (11,383 ) $ (35,963 ) $ (21,520 ) Add: Stock-based compensation expense 5,189 2,052 10,870 3,811 Add: Depreciation and amortization 273 298 556 597 Less: Legal settlement — — (590 ) — Non-GAAP Net loss $ (13,706 ) $ (9,033 ) $ (25,127 ) $ (17,112 ) Expand
Business Wire
an hour ago
- Business Wire
NBA Champion & Web3 Expert Tristan Thompson Appointed as Chief Digital Equity Officer for Telecoms Trailblazer World Mobile - Focused on Their Shared Mission of Bringing Affordable, Community-Owned In
LOS ANGELES--(BUSINESS WIRE)--NBA champion, tech and Web3 expert Tristan Thompson is stepping off the court and into the skies—literally, as he announces his new role as telecoms trailblazer World Mobile's first Chief Digital Equity Officer with its game-changing aerospace subsidiary World Mobile Stratospheric and mission to connect the 3 billion people who still live without internet access. Thompson is teaming up with the global decentralized wireless network to spotlight overlooked digital divides and champion a future where communities own their connectivity. In a world where connectivity means access to education, opportunity, and economic freedom, Thompson is leading a bold new approach: telecoms from the stratosphere. The announcement kicks off a multi-tier campaign aimed at raising awareness around hidden infrastructure gaps — not only in rural regions but also in places people least expect, like Hidden Hills in Los Angeles or pockets of inner-city Cleveland. In his new role, Thompson will work closely with World Mobile to drive visibility and real-world solutions in these areas. As part of this initiative, Thompson is introducing the Community Connectivity Fund, a multi-million-dollar effort designed to help low-income neighborhoods gain access to affordable, high-speed internet through World Mobile's decentralized model. The fund will support pilot programs, local infrastructure installations, and education around community ownership of mobile networks. As an additional strategic move, World Mobile has announced an unprecedented partnership with Protelindo, Indonesia's largest digital infrastructure company, to develop and deploy a pioneering stratospheric connectivity network. Powered by hydrogen-fueled, fixed-wing aircraft, the solution will support internet access for hundreds of millions of global web users, particularly in underserved regions, through sustainable and cost-effective technology. The pioneering network leverages hydrogen-powered, fixed-wing aircraft operating as High-Altitude Platform Systems (HAPS), capable of maintaining a stationary position at altitudes of approximately 20,000 meters. Utilizing World Mobile's blockchain-based infrastructure, these aircraft will provide direct-to-handset internet access, supporting hundreds of thousands of concurrent users with cellular connectivity. Central to this innovation is World Mobile's native WMTx token, which serves as the economic backbone for the entire network. The blockchain-secured token manages on-chain settlements, permissioned network access, and economic incentives, creating a self-sustaining value loop. Users, infrastructure providers, and node operators are economically aligned, ensuring continuous expansion and sustainability of the network. Micky Watkins, CEO of World Mobile, said in a statement, 'This partnership embodies the potential of blockchain and decentralized economics to reshape global connectivity. By integrating token-driven incentives with advanced aerospace technology, we're creating a resilient and economically viable model for bringing reliable internet to underserved regions at unprecedented scale.' Indra Gunawan, senior representative at Protelindo added, 'World Mobile's blockchain-based approach to connectivity infrastructure addresses key challenges faced by geographically diverse countries like Indonesia. We see tremendous potential in leveraging this technology to bring consistent, scalable internet access to communities currently beyond traditional reach.' The hydrogen-powered aircraft at the heart of the initiative have already undergone successful testing with major telecom companies in the UK and Middle East. Capable of delivering connectivity across vast regions, the aircraft can efficiently cover remote and rural areas typically underserved by fiber and traditional cellular networks. Hydrogen fuel also drastically reduces environmental impact, achieving a projected 99% reduction in carbon emissions compared to satellite-based solutions. Deployment of the blockchain-enabled aircraft will initially target strategic geographic markets such as Indonesia and the United States, where challenging terrains and underserved communities stand to benefit significantly. Despite advanced telecom infrastructure in the U.S., approximately 11% of citizens lack reliable connectivity, demonstrating the pressing need for innovative solutions. World Mobile's DePIN initiative represents a significant leap forward for blockchain-based infrastructure, merging decentralized economic incentives with real-world utility. The network not only promises expanded internet access but also introduces a sustainable, token-driven economic model that can be replicated globally. Thompson's role with World Mobile merges influence, personal journey, and impact. Growing up with limited access to opportunity, and now facing connectivity issues in even the most developed areas, he is focused on the mission to connect the unconnected — starting in the neighborhoods that often fall through the cracks. His appointment marks a major step in World Mobile's efforts to educate and empower people to not only access the internet but also benefit from the infrastructure behind it. Together, World Mobile and Tristan Thompson are not only rethinking who gets connected, but who gets to own the network — creating a world where everyone has the power to build and benefit from their own digital future. With Tristan Thompson on board, World Mobile isn't just changing telecoms—it's changing lives. The mission is clear: everyone, everywhere deserves to be connected. About World Mobile World Mobile is revolutionizing global connectivity through its blockchain-based Decentralized Physical Infrastructure Network (DePIN), empowering individuals and communities to build, maintain, and monetize telecom infrastructure through blockchain-driven economic incentives. Learn more at
Business Wire
an hour ago
- Business Wire
The Toro Company Names Edric C. Funk President and Chief Operating Officer
BLOOMINGTON, Minn.--(BUSINESS WIRE)--The Toro Company (NYSE: TTC), a leading global provider of solutions for the outdoor environment, today announced that Edric C. Funk has been appointed president and chief operating officer, effective September 1, 2025. Funk, a 29-year veteran of the company, has served as group vice president of Golf, Grounds and Irrigation since 2022. In this new role, he will assume responsibility for all of the company's global businesses and integrated supply chain operations, continuing to report to Richard M. Olson, chairman and chief executive officer. 'Edric's track record of driving business performance and fostering innovation uniquely equips him for the role of chief operating officer,' said Olson. 'Throughout his tenure, Edric has consistently delivered strong financial results and value creation across diverse technical and business functions – directly contributing to our growth and competitive position. His deep understanding of our customers, and technologies coupled with a disciplined strategic approach, will continue to propel The Toro Company forward and create value for all stakeholders.' Since joining The Toro Company in 1996 as a design engineer, Funk transitioned to marketing in 2003 and held roles of increasing responsibility in the company's Residential, Landscape Contractor, International and Commercial businesses. In 2014, he was promoted to director of global product management for the Commercial and International businesses, and in 2017 was named managing director of the company's Center for Technology, Research & Innovation (CTRI). Funk went on to become the general manager of the Sitework Systems business in 2020, before being promoted to group vice present of Golf, Grounds and Irrigation, where he has played an influential role in driving performance across multiple professional product categories. Funk was instrumental in the acquisitions of both Left Hand Robotics and TURFLYNX, which accelerated the development of robotic mowing platforms recently introduced to the market. He also elevated the organization's technology community through the creation of its Technology Forum and has championed integrated smart systems delivering more holistic solutions for customers. In 2020, he was recognized by Golf, Inc. as one of the Most Innovative People in Golf. 'I am honored to serve in this role, and I look forward to working alongside our talented team to drive operational performance across our businesses, with a focus on accelerating profitable growth, advancing the company's technology roadmap and optimizing global supply chain operations,' said Funk. Funk received a Bachelor of Science in engineering from the University of Minnesota and an MBA from The University of Minnesota – Carlson School of Management. He also has a professional certificate in innovation and technology from the Massachusetts Institute of Technology. He serves on the boards of the National Golf Foundation, The Toro Company Foundation, and Red Iron Acceptance. About The Toro Company The Toro Company (NYSE: TTC) is a leading global provider of solutions for the outdoor environment including turf and landscape maintenance, snow and ice management, underground utility construction, rental and specialty construction, and irrigation and outdoor lighting solutions. With net sales of $4.6 billion in fiscal 2024, The Toro Company's global presence extends to more than 125 countries through a family of brands that includes Toro, Ditch Witch, Exmark, Spartan, BOSS, Ventrac, American Augers, Subsite, HammerHead, Radius, Perrot, Hayter, Unique Lighting Systems, Irritrol, and Lawn-Boy. Through constant innovation and caring relationships built on trust and integrity, The Toro Company and its family of brands have built a legacy of excellence by helping customers work on golf courses, sports fields, construction sites, public green spaces, commercial and residential properties and agricultural operations. For more information, visit
